These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Malignant form of papillary-pigmented skin dystrophy (acanthosis nigricans malignum)]. Shupen'ko NM; Svirid AA Vestn Dermatol Venerol; 1980 Feb; (2):37-40. PubMed ID: 7355624 [No Abstract] [Full Text] [Related]
24. Malignant acanthosis nigricans associated with prostate cancer: a case report. Kubicka-Wołkowska J; Dębska-Szmich S; Lisik-Habib M; Noweta M; Potemski P BMC Urol; 2014 Nov; 14():88. PubMed ID: 25399333 [TBL] [Abstract][Full Text] [Related]
25. [Relations between acanthosis nigricans benigna and pseudoacanthosis nigricans]. Lang E; Schmidt R Hautarzt; 1982 Dec; 33(12):640-5. PubMed ID: 7161102 [TBL] [Abstract][Full Text] [Related]
26. Brown patches, skin tags on axilla. Are this patient's velvety plaques related to his obesity and diabetes? Levine N Geriatrics; 1996 Oct; 51(10):27. PubMed ID: 8863754 [No Abstract] [Full Text] [Related]
27. Acanthosis nigricans with endometrial carcinoma: case report and review of the literature. Mekhail TM; Markman M Gynecol Oncol; 2002 Feb; 84(2):332-4. PubMed ID: 11812096 [TBL] [Abstract][Full Text] [Related]
28. Malignant acanthosis nigricans and tripe palms in a patient with endometrial adenocarcinoma--a case report and review of literature. Gorisek B; Krajnc I; Rems D; Kuhelj J Gynecol Oncol; 1997 Jun; 65(3):539-42. PubMed ID: 9190991 [TBL] [Abstract][Full Text] [Related]
29. [Systemic photochemotherapy (PUVA) in acanthosis nigricans maligna: regression of keratosis, hyperpigmentation and pruritus]. Bonnekoh B; Thiele B; Merk H; Mahrle G Z Hautkr; 1989 Dec; 64(12):1059-62. PubMed ID: 2561241 [TBL] [Abstract][Full Text] [Related]
30. [On the difficulty of differentiation of malignant and benign acanthosis nigricans]. Bernhardt E Przegl Dermatol; 1968; 55(6):769-73. PubMed ID: 5709701 [No Abstract] [Full Text] [Related]
31. [Dowling-Degos disease]. Hammer G Z Hautkr; 1984 Sep; 59(17):1179-82. PubMed ID: 6485461 [TBL] [Abstract][Full Text] [Related]
32. [Diagnosis and differential diagnosis of oral hyperpigmentation]. Langford A; Ruf B Quintessenz; 1990 Dec; 41(12):1989-2001. PubMed ID: 2101992 [No Abstract] [Full Text] [Related]
33. [Generalized hyperpigmentation and malignant acanthosis nigricans. A case of a patient with hereditary hemochromatosis and gastric cancer]. Kalt A; Wagner A; Zeuzem S; Tilgen W; Reichrath J Hautarzt; 2005 Jun; 56(6):581-5. PubMed ID: 15645193 [TBL] [Abstract][Full Text] [Related]
34. Stereochemistry of dihydrofolate reductase inhibitor antitumor agents: molecular structure of "Baker's antifol" (NSC 139105, triazinate) and "insoluble Baker's antifol" (NSC 113423). Camerman A; Smith HW; Camerman N Biochem Biophys Res Commun; 1978 Jul; 83(1):87-93. PubMed ID: 697826 [No Abstract] [Full Text] [Related]
35. A case of hyperpigmentation and acanthosis nigricans by testosterone injections. Karadag A; Kavala M; Demir F; Turkoğlu Z; Kartal I; Zemheri E Hum Exp Toxicol; 2014 Dec; 33(12):1297-301. PubMed ID: 24505054 [TBL] [Abstract][Full Text] [Related]
36. Dowling-Degos disease. Georgescu EF; Stănescu L; Popescu CF; Comănescu M; Georgescu I Rom J Morphol Embryol; 2010; 51(1):181-5. PubMed ID: 20191141 [TBL] [Abstract][Full Text] [Related]
40. Acanthosis nigricans in association with congenital adrenal hyperplasia: resolution after treatment. Case report. Kurtoğlu S; Atabek ME; Keskin M; Canöz O Turk J Pediatr; 2005; 47(2):183-7. PubMed ID: 16052863 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]